coronaviru
diseas
viral
pandem
caus
sever
acut
respiratori
syndrom
coronaviru
predominantli
defin
respiratori
symptom
cardiac
complic
includ
arrhythmia
heart
failur
viral
myocard
also
preval
although
system
ischem
inflammatori
respons
caus
detriment
affect
cardiac
function
direct
impact
infect
human
cardiomyocyt
wellunderstood
use
human
induc
pluripot
stem
cellderiv
cardiomyocyt
hipsccm
model
system
examin
mechan
cardiomyocytespecif
infect
microscopi
immunofluoresc
demonstr
enter
replic
within
hipsccm
local
perinuclear
locat
within
cytoplasm
viral
cytopath
effect
induc
hipsccm
apoptosi
cessat
beat
hour
infect
studi
show
infect
hipsccm
vitro
establish
model
elucid
mechan
infect
potenti
cardiacspecif
antivir
drug
screen
platform
coronaviru
diseas
caus
sever
acut
respiratori
syndrom
coronaviru
declar
intern
pandem
caus
hospit
death
hundr
thousand
peopl
worldwid
ramaiah
arumugaswami
singlestrand
envelop
rna
viru
known
use
receptor
enter
host
lung
tissu
follow
rapid
viral
replic
hoffmann
et
al
clinic
present
demonstr
predominantli
pulmonari
symptom
includ
cough
short
breath
pneumonia
acut
respiratori
distress
syndrom
madjid
et
al
howev
mount
evid
infect
may
caus
cardiac
complic
includ
elev
cardiac
stress
biomark
arrhythmia
heart
failur
madjid
et
al
recent
studi
demonstr
significantli
elev
troponin
level
among
patient
indic
cardiac
injuri
notabl
cardiac
injuri
associ
increas
risk
mortal
shi
et
al
etiolog
cardiac
injuri
howev
remain
unclear
cardiac
injuri
may
ischemiamedi
profound
inflammatori
hemodynam
impact
seen
hypothes
caus
atherosclerot
plaqu
ruptur
oxygen
supplydemand
mismatch
result
ischemia
madjid
et
al
altern
cardiac
tissu
express
receptor
suggest
feasibl
direct
viral
intern
cardiomyocyt
chen
et
al
inde
case
studi
rais
suspicion
cardiac
injuri
mediat
direct
myocardi
viral
infect
result
fulmin
myocard
hu
et
al
tavazzi
et
al
zeng
et
al
order
gain
insight
cardiac
pathophysiolog
critic
determin
whether
directli
infect
isol
human
cardiomyocyt
vitro
elucid
pathogen
mechan
cardiac
injuri
could
ultim
guid
therapeut
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
strategi
antivir
agent
could
potenti
mitig
cardiac
complic
underli
mechan
cardiac
injuri
direct
myocardi
viral
infect
primari
human
cardiomyocyt
difficult
obtain
maintain
research
use
improv
method
convert
human
induc
pluripot
stem
cell
hipsc
multipl
somat
lineag
enabl
vitro
mass
product
patientspecif
cell
includ
hipscderiv
cardiomyocyt
hipsccm
sharma
et
al
hipsccm
express
relev
protein
found
adult
human
cm
spontan
contract
made
week
use
defin
differenti
protocol
genet
custom
use
genom
edit
sharma
et
al
hipsccm
express
increas
day
differenti
churko
et
al
hipsccm
also
respons
inotrop
drug
norepinephrin
beat
rate
control
via
electr
stimul
toepfer
et
al
hipsccm
purifi
replat
downstream
applic
research
group
academia
industri
util
cell
cardiovascular
diseas
model
highthroughput
drug
screen
assay
hipsccm
recapitul
cellular
phenotyp
cardiovascular
diseas
includ
variou
form
cardiomyopathi
lan
et
al
sun
et
al
druginduc
cardiotox
burridg
et
al
sharma
et
al
notabl
hipsccm
also
shown
promis
vitro
model
studi
mechan
direct
cardiomyocyt
viral
infect
context
viral
myocard
previou
studi
demonstr
coxsackieviru
one
major
caus
agent
viral
myocard
rapidli
infect
prolifer
within
hipsccm
sharma
et
al
like
positivesens
singlestrand
rna
viru
although
unlik
viral
envelop
hipsccm
produc
coxsacki
adenoviru
receptor
protein
need
infect
detriment
virusinduc
cytopath
effect
observ
hipsccm
within
hour
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
infect
manifest
cell
death
contractil
irregular
importantli
studi
also
establish
hipsccm
cardiacspecif
antivir
drug
screen
platform
demonstr
drug
interferon
beta
ribavirin
stymi
prolifer
vitro
sharma
et
al
interferon
beta
abl
transcript
activ
viral
clearanc
gene
network
hipsccm
aforement
foundat
viral
myocard
studi
extend
assess
effect
hipsccm
show
hipsccm
suscept
infect
result
function
alter
cytopath
effect
cellular
phenotyp
occur
absenc
inflammatori
hemodynam
impact
result
provid
new
mechanist
insight
cardiac
manifest
suggest
heart
may
suscept
direct
infect
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
hipsc
control
line
gener
cedarssinai
medic
center
ipsc
core
peripher
blood
mononuclear
cell
shown
fulli
pluripot
laperl
et
al
hipsc
differenti
hipsccm
use
establish
monolay
differenti
protocol
util
small
molecul
modul
wnt
signal
sharma
et
al
differenti
hipsccm
metabol
purifi
depriv
cell
glucos
previous
publish
sharma
et
al
purifi
hipsccm
express
standard
cardiac
sarcomer
marker
cardiac
troponin
ctnt
figur
purifi
hipsccm
replat
plate
cell
per
well
allow
regain
contractil
supplement
movi
subject
infect
obtain
biodefens
emerg
infect
bei
resourc
nation
institut
allergi
infecti
diseas
niaid
titer
cell
see
method
hipsccm
infect
multipl
infect
moi
hour
mock
treatment
without
viru
serv
control
condit
order
determin
viru
could
enter
prolifer
within
hipsccm
cell
infect
mock
condit
stain
cardiac
marker
cardiac
troponin
ctnt
viral
capsid
spike
protein
figur
infect
hipsccm
stain
posit
spike
protein
suggest
establish
activ
infect
hipsc
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
determin
induc
cytopath
effect
hipsccm
mock
infect
hipsccm
stain
apoptosi
marker
cleav
well
doubl
strand
rna
dsrna
intermedi
uniqu
posit
sens
rna
viru
infect
figur
dsrna
spike
protein
stain
repres
two
independ
assay
visual
viral
uptak
genom
replic
hipsccm
proport
infect
cell
posit
dsrna
also
stain
posit
cleav
indic
hipsccm
undergo
virusinduc
apoptosi
notabl
spike
protein
dsrna
intermedi
local
perinuclear
region
hipsccm
figur
consist
prior
result
coronaviru
infect
noncardiomyocyt
hagemeij
et
al
coxsackieviru
infect
hipsccm
sharma
et
al
suggest
presenc
viroplasm
wherebi
hipsccm
ribosom
machineri
membran
compon
coopt
viral
replic
protein
translat
quantif
stain
cell
demonstr
percent
total
cell
posit
dsrna
spike
protein
well
cleav
figur
simpl
beat
rate
contractil
analysi
also
conduct
wherebi
second
video
taken
well
contain
mock
infect
hipsccm
supplement
movi
function
infect
hipsccm
ceas
beat
hour
infect
wherea
mock
well
continu
contract
figur
taken
togeth
result
indic
hipsccm
suscept
infect
downstream
detriment
cytopath
effect
may
abl
replic
distinct
perinuclear
locat
within
hipsccm
coopt
cellular
organel
viral
protein
translat
infect
significantli
reduc
function
contractil
hipsccm
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
result
present
establish
first
time
human
ipscderiv
cardiomyocyt
suscept
direct
infect
viru
may
induc
detriment
cytopath
effect
cell
moi
wherebi
approxim
viral
particl
introduc
per
cell
hipsccm
experienc
cytopath
effect
hour
infect
viru
presum
enter
cell
receptor
previous
shown
produc
hipsccm
churko
et
al
immunostain
two
compon
uniqu
dsrna
intermedi
spike
capsid
protein
respons
viral
entri
virion
particl
assembl
demonstr
novel
coronaviru
enter
hipsccm
unleash
rna
cargo
hijack
host
hipsccm
translat
machineri
produc
new
viral
compon
notabl
dsrna
spike
stain
local
perinuclear
region
indic
format
hallmark
viroplasm
structur
within
hipsccm
viroplasm
inclus
bodi
within
cytoplasm
recruit
host
cellular
compon
ribosom
chaperon
mitochondria
establish
de
facto
viral
replic
factori
within
cell
netherton
wileman
perinuclear
viral
compon
accumul
report
vitro
coronaviru
infect
studi
hagemeij
et
al
parallel
seen
hipsccm
infect
coxsackieviru
sharma
et
al
presum
increas
viral
load
within
hipsccm
activ
downstream
apoptot
event
indic
alter
cellular
morpholog
increas
product
cleav
parallel
stain
show
viral
accumul
function
alter
hipsccm
contractil
cell
ceas
beat
caus
dramat
function
chang
hipsccm
beat
must
investig
perhap
cytopath
effect
associ
hipsccm
apoptosi
significantli
disrupt
cellcel
gap
junction
therefor
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
impair
proper
excitationcontract
coupl
within
cardiomyocyt
inde
signific
alter
calcium
handl
contractil
similarli
observ
hipsccm
sharma
et
al
addit
work
remain
done
elucid
cardiomyocytespecif
effect
particular
impact
cell
function
gene
express
cellular
immatur
hipscderiv
cell
type
must
consid
model
known
hipsccm
electrophysiolog
structur
genet
immatur
comparison
adult
counterpart
bedada
et
al
although
biomechan
effort
matur
cell
toward
adult
phenotyp
recent
gain
traction
ronaldsonbouchard
et
al
howev
even
immatur
cell
current
studi
show
overt
virusinduc
cardiotox
physiolog
effect
low
moi
sinc
express
increas
hipsccm
matur
vitro
cultur
churko
et
al
one
could
hypothes
matur
older
cardiomyocyt
would
even
suscept
infect
signific
addit
data
need
test
possibl
result
present
isol
vitro
system
devoid
immun
system
compon
thought
critic
mani
aspect
viral
respons
vivo
shi
et
al
result
myocard
definit
inflamm
myocardium
caus
immun
cell
infiltr
may
may
result
direct
cardiomyocyt
viral
infect
howev
shown
human
ipscderiv
cardiomyocyt
clearli
suscept
infect
even
absenc
immun
respons
suggest
possibl
direct
infect
heart
play
role
clinic
syndrom
inde
recent
studi
use
biopsi
heart
tissu
show
viru
myocardium
patient
tavazzi
et
al
need
replic
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
rais
question
whether
enter
heart
via
virem
phase
macrophag
clear
viru
lung
nevertheless
studi
suggest
cardiomyocyt
infect
may
contribut
varieti
cardiac
clinic
sequela
present
patient
arrhythmia
elev
cardiac
troponin
biomark
heart
failur
predict
futur
studi
abl
use
hipsccm
cardiacspecif
antivir
drug
screen
platform
similar
fashion
previou
studi
coxsackieviru
hipsccm
sharma
et
al
varieti
antivir
approach
rang
repurpos
small
molecul
nucleosid
analogu
viral
polymeras
inhibitor
novel
antibodi
antisens
oligonucleotid
propos
current
test
vitro
clinic
trial
harrison
hipsccm
could
serv
cardiacspecif
auxiliari
cell
type
vitro
preclin
efficaci
studi
drug
aim
stymi
prolifer
parallel
druginduc
arrhythmia
qtinterv
prolong
also
examin
antivir
compound
preclin
develop
given
exist
drug
treatment
exhibit
offtarget
cardiotox
roden
et
al
due
enorm
current
pandem
increas
evid
associ
cardiac
symptom
innov
approach
use
technolog
hipsccm
present
critic
understand
counteract
infect
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
appropri
institut
review
board
irb
stem
cell
research
oversight
committe
scro
consult
ucla
cedarssinai
medic
center
hipsc
line
deriv
human
peripher
blood
mononuclear
cell
publish
previous
laperl
et
al
cell
line
obtain
cedarssinai
medic
center
ipsc
core
facil
deriv
irbscro
protocol
ipsc
core
repositori
stem
cell
program
ipsc
differenti
work
svendsen
lab
carri
svendsen
stem
cell
program
author
cedarssinai
medic
center
irb
hipsccm
gener
hipsc
use
smallmolecul
mediat
differenti
approach
modul
wnt
signal
sharma
et
al
briefli
approach
use
inhibitor
initi
mesoderm
specif
follow
wnt
inhibitor
initi
cardiac
specif
cell
began
beat
approxim
day
postdifferenti
cardiomyocyt
metabol
select
differenti
cell
use
glucos
depriv
previous
describ
sharma
et
al
select
hipsccm
replat
monolay
plate
format
cell
per
well
hipsccm
cultur
medium
rpmi
supplement
insulin
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
isol
obtain
biodefens
emerg
importantli
studi
involv
infect
hipsccm
conduct
within
biosafeti
level
facil
ucla
passag
cell
viral
stock
aliquot
store
c
viru
titer
measur
cell
assay
cell
cultur
dmem
growth
media
contain
fetal
bovin
serum
mm
lglutamin
penicillin
unitsml
streptomycin
unitsml
mm
hepe
cell
incub
hipsccm
infect
viral
inoculum
moi
prepar
use
serumfre
media
cultur
media
well
contain
hipsccm
remov
replac
prepar
inoculum
mock
infect
serumfre
media
alon
ad
inocul
plate
incub
hour
inoculum
spread
gentli
tilt
plate
sideway
everi
minut
end
incub
inoculum
replac
fresh
hipsccm
cultur
medium
cell
remain
hour
analysi
hour
infect
mock
live
cell
imag
video
obtain
bright
field
microscop
leica
dmil
led
immunofluoresc
separ
well
hipsccm
fix
paraformaldehyd
phosphatebuff
salin
pb
minut
fix
sampl
permeabil
block
hour
block
solut
contain
pb
bovin
serum
albumin
donkey
serum
goat
serum
triton
primari
antibodi
dilut
block
solut
ad
sampl
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
overnight
follow
antibodi
dilut
use
sampl
rins
time
minut
pb
contain
triton
follow
dapi
dilut
pb
minut
immunofluoresc
imag
quantifi
use
imagej
softwar
dapi
use
count
total
cell
number
order
obtain
percentag
cell
posit
dsrna
spike
protein
cleav
thirtysecond
video
clip
taken
mock
infect
hipsccm
hour
viral
infect
beatsperminut
measur
obtain
manual
count
individu
beat
video
multipli
extrapol
minut
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
statist
analys
student
test
use
comparison
two
dataset
error
bar
refer
standard
deviat
p
valu
consid
statist
signific
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
va
cn
design
analys
analyz
data
draft
manuscript
gg
conduct
experi
acquir
data
va
cn
analyz
data
author
contribut
final
manuscript
acknowledg
review
repres
area
studi
dramat
grow
relev
thu
apolog
author
whose
work
abl
includ
author
declar
compet
interest
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
figur
intern
replic
within
hipsccm
vitro
elicit
cytopath
effect
contractil
alter
human
ipsccm
exhibit
standard
sarcomer
marker
includ
cardiac
troponin
ctnt
dapi
nuclear
counterstain
b
immunofluoresc
ctnt
spike
protein
demonstr
hipsccm
infect
spike
protein
present
mock
infect
cultur
c
hipsccm
infect
mock
infect
exhibit
sign
cellular
apoptosi
indic
morpholog
chang
seen
bright
field
bf
cleav
product
second
antibodi
mark
viralspecif
doublestrand
intermedi
rna
dsrna
magnifi
inset
panel
b
show
merg
immunofluoresc
imag
spike
protein
dapi
arrow
indic
perinuclear
accumul
viral
particl
suggest
activ
viral
protein
translat
genom
replic
perinuclear
ribosom
membran
compart
e
magnifi
inset
panel
c
show
merg
immunofluoresc
imag
dsrna
dapi
arrow
indic
perinuclear
viral
replic
site
f
quantif
immunofluoresc
indic
percentag
total
dapiposit
cell
posit
spike
protein
viral
dsrna
cleav
hipsccm
infect
compar
mock
infect
imag
quantifi
stain
mock
infect
condit
g
quantif
beat
per
minut
well
contain
hipsccm
mock
infect
versu
well
contain
hipsccm
infect
video
record
condit
see
supplement
movi
repres
video
clip
indic
p
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
